4-100479931-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016242.4(EMCN):āc.173G>Cā(p.Gly58Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000411 in 1,607,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016242.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EMCN | NM_016242.4 | c.173G>C | p.Gly58Ala | missense_variant | 2/12 | ENST00000296420.9 | NP_057326.2 | |
LOC124900740 | XR_007058203.1 | n.69-31202C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EMCN | ENST00000296420.9 | c.173G>C | p.Gly58Ala | missense_variant | 2/12 | 1 | NM_016242.4 | ENSP00000296420 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151988Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000287 AC: 7AN: 244214Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 132140
GnomAD4 exome AF: 0.0000385 AC: 56AN: 1455130Hom.: 0 Cov.: 30 AF XY: 0.0000345 AC XY: 25AN XY: 723818
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151988Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.173G>C (p.G58A) alteration is located in exon 2 (coding exon 2) of the EMCN gene. This alteration results from a G to C substitution at nucleotide position 173, causing the glycine (G) at amino acid position 58 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at